• Explore /
  • Poster
  • / A phase II study of enzalutamide (Enz) with dutasteride (Dut) or finasteride (Fin) in men ≥ 65 years with hormone-naive systemic prostate cancer (HNSPCa).

A phase II study of enzalutamide (Enz) with dutasteride (Dut) or finasteride (Fin) in men ≥ 65 years with hormone-naive systemic prostate cancer (HNSPCa).

Abstract Poster

Authors

null

Deepak Kilari

Medical College of Wisconsin, Milwaukee, WI

Deepak Kilari , Elizabeth A. Guancial , Deepak M. Sahasrabudhe , Kathryn A. Bylow , John D. Burfeind , Kaylinn Musto , Changyong Feng , Edward M. Messing , Supriya Gupta Mohile , Chunkit Fung

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT02213107

Citation

J Clin Oncol 35, 2017 (suppl 6S; abstract 179)

DOI

10.1200/JCO.2017.35.6_suppl.179

Abstract #

179

Poster Bd #

G8

Abstract Disclosures

Similar Posters

First Author: Bertrand F. Tombal

First Author: Bertrand F. Tombal

Poster

2014 Genitourinary Cancers Symposium

Enzalutamide monotherapy: Extended follow-up of a phase II study in hormone-naive prostate cancer patients.

Enzalutamide monotherapy: Extended follow-up of a phase II study in hormone-naive prostate cancer patients.

First Author: Bertrand Tombal

First Author: Deepak Kilari